icon
0%

Leidos Holdings LDOS - News Analyzed: 10,700 - Last Week: 100 - Last Month: 400

Leidos Holdings LDOS: Q4 Results, Major Contracts, and Market Reactions.

Leidos Holdings LDOS: Q4 Results, Major Contracts, and Market Reactions.
Leidos Holdings (LDOS) has been a major topic, with numerous pertinent updates surrounding this bio-tech company. Prominent investment corporations such as IAM Advisory LLC and Mariner LLC have considerably invested in LDOS, indicating positive investor sentiment. LDOS's valutation is frequently diverged following significant developments like New Defense Cloud, AI Cybersecurity Wins, as well as the TFDM implementation and bolstering growth outlook. Amidst this, LDOS's shares have experienced fluctuating trends, notably dropping by 3.81% on March 16. Upcoming initiatives of LDOS, such as the offering of its Small Cruise Missile to the US Air Force and the modernization of U.S Air Force cloud operations for enhanced mission readiness, appear promising. LDOS has also signed a major contract with the US Air Force. A downturn in the share price prompted the negotiation of its valuation while RBC decreased LDOS's target from $235 to $215. Among other noticeable movements, LDOS released its Q4 and FY 2025 financial results, declared a $0.43 quarterly dividend, and granted stock units to executives.

Leidos Holdings LDOS News Analytics from Wed, 20 Aug 2025 07:00:00 GMT to Sat, 21 Mar 2026 11:08:56 GMT -

The email address you have entered is invalid.